- Previous Close
21.60 - Open
21.60 - Bid --
- Ask 21.20 x --
- Day's Range
21.20 - 21.60 - 52 Week Range
18.70 - 25.60 - Volume
0 - Avg. Volume
12 - Market Cap (intraday)
14.512B - Beta (5Y Monthly) 1.35
- PE Ratio (TTM)
49.30 - EPS (TTM)
0.43 - Earnings Date Feb 12, 2025 - Feb 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
www.avantorsciences.com14,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AVTR.VI
View MorePerformance Overview: AVTR.VI
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVTR.VI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVTR.VI
View MoreValuation Measures
Market Cap
14.51B
Enterprise Value
18.94B
Trailing P/E
49.49
Forward P/E
19.72
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.23
Price/Book (mrq)
2.73
Enterprise Value/Revenue
2.91
Enterprise Value/EBITDA
19.19
Financial Highlights
Profitability and Income Statement
Profit Margin
4.54%
Return on Assets (ttm)
3.27%
Return on Equity (ttm)
5.81%
Revenue (ttm)
6.82B
Net Income Avi to Common (ttm)
309.6M
Diluted EPS (ttm)
0.43
Balance Sheet and Cash Flow
Total Cash (mrq)
285.3M
Total Debt/Equity (mrq)
88.62%
Levered Free Cash Flow (ttm)
658.37M